Last Updated : March 28, 2024
Details
FilesGeneric Name:
aflibercept 8mg/0.07mL
Project Status:
Active
Therapeutic Area:
macular degeneration, age related
Manufacturer:
Bayer Inc.
Call for patient/clinician input open:
Brand Name:
Eylea HD
Project Line:
Reimbursement Review
Project Number:
SR0812-000
Call for patient/clinician input closed:
NOC Status at Filing:
Pre NOC
Biosimilar:
No
Manufacturer Requested Reimbursement Criteria1:
For the treatment of neovascular (wet) age-related macular degeneration (nAMD), with reimbursement criteria similar to those used for other approved and reimbursed anti-vascular endothelial growth factor (VEGF) therapies.
Submission Type:
Initial
Fee Schedule:
Schedule A
Indications:
Treatment of neovascular (wet) age-related macular degeneration (nAMD).
- The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of CADTH. Reimbursement criteria from CADTH will be documented in the final recommendation, if applicable.
| Call for patient/clinician input open | 07-Jul-23 |
|---|---|
| Call for patient/clinician input closed | 01-Sep-23 |
| Clarification: - Patient input submission received from Fighting Blindness Canada, The Canadian Council of the Blind, CNIB, Vision Loss Rehabilitation Canada, International Federation on Ageing and the Canadian Council of the Blind | |
| Submission received | 18-Aug-23 |
| Submission accepted | 05-Sep-23 |
| Clarification: - Submission was not accepted for review on 01 Sep 2023 | |
| Review initiated | 06-Sep-23 |
| Draft CADTH review report(s) provided to sponsor for comment | 30-Nov-23 |
| Deadline for sponsors comments | 11-Dec-23 |
| CADTH review report(s) and responses to comments provided to sponsor | 12-Jan-24 |
| Expert committee meeting (initial) | 24-Jan-24 |
| Draft recommendation issued to sponsor | 08-Feb-24 |
| Draft recommendation posted for stakeholder feedback | 15-Feb-24 |
| End of feedback period | 01-Mar-24 |
| Clarification: - Reconsideration: major revisions requested by sponsor | |
| Expert committee meeting | 22-May-24 |
Files
Last Updated : March 28, 2024